Cargando…
Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
OBJECTIVE: Presence of high-risk factor in cervical cancer is known to be associated with decreased survival outcomes. However, the significance of multiple high-risk factors in early-stage cervical cancer related to survival outcomes, recurrence patterns, and treatment implications is not well eluc...
Autores principales: | Matsuo, Koji, Mabuchi, Seiji, Okazawa, Mika, Kawano, Mahiru, Kuroda, Hiromasa, Kamiura, Shoji, Kimura, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302282/ https://www.ncbi.nlm.nih.gov/pubmed/25310856 http://dx.doi.org/10.3802/jgo.2015.26.1.3 |
Ejemplares similares
-
Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
por: Matsuo, K, et al.
Publicado: (2013) -
Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review
por: Kozasa, Katsumi, et al.
Publicado: (2017) -
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
por: Kawano, Mahiru, et al.
Publicado: (2015) -
Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
por: Takahashi, Ryoko, et al.
Publicado: (2016) -
Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients
por: Mabuchi, Seiji, et al.
Publicado: (2017)